Remove Financial Analysis Remove Pharmaceutical Remove Planning
article thumbnail

5 Excel-heavy Pain Points still Dragging down finance teams in 2025

The Finance Weekly

A finance director at a large niche pharmaceutical company told us: “We have a lot of manual processes and inputting and that type of stuff which I am trying to get away from. One company we spoke to–a $110M equipment leasing firm–has been looking for a way out of this Excel mess for three years.

article thumbnail

Return on Equity, Earnings Yield and Market Efficiency: Back to Basics!

Musings on Markets

On business B, you have a challenge, since it does seem irrational that an entrepreneur would enter a bad business, and while that irrationality cannot be ruled out (perhaps the entrepreneur thinks that earning any profit makes for a good business), the reality is that outside events can wreak havoc on the bet paid plans of businesses.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

5 Excel-heavy Pain Points still Dragging down finance teams in 2024

The Finance Weekly

A finance director at a large niche pharmaceutical company told us: “We have a lot of manual processes and inputting and that type of stuff which I am trying to get away from. Under this familiar process, financial personnel export data from their organization's software, typically the company's Enterprise Resource Planning (ERP) system.

article thumbnail

Transcript: Tony Kim, Blackrock Active Technology

Barry Ritholtz

What were the career plans? Tony Kim : Career plans? I was particularly, I was in, I was working in, on the East coast and, you know, any, everything from like pharmaceutical to automotive to, to what a, what a distribution network looked like. And that’s when then you get into the financial analysis.